Health security strategy: strengthening Europe’s pharma industry base
A resilient and dynamic ecosystem for healthcare innovation is key to strengthening the European Union. A comprehensive strategy brings patient
Read more
Health
Enhancing the resilience and the competitiveness of the pharma supply chains to secure access to critical medicines and other medical countermeasures
When the COVID-19 pandemic hit, countries around the globe were caught off guard. In Europe, each country initially responded on
Read more
The value of investing in Advanced Therapy Medicinal Products: combining sustainability, innovation and respect for patients’ rights
To move towards the European Health Union, we probably also need to go beyond the current narrative concerning the European
Read more
An EU Immunisation Strategy: making Europe more resilient
Vaccination is critical to our health security infrastructure, laying the foundation for a more innovative, healthier, prosperous Europe, writes Sibilia
Read more
The patient at the center of all health policies
In the wake of the global COVID-19 crisis, Europe stands at a critical juncture in shaping its health policies and
Read more
Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read more
A critical medicines act for Europe
Introduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read more
Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe
As discussions surrounding the revision of the EU pharmaceutical legislation take place, two fundamental questions come to the forefront: how
Read more